Regeneron
Trade Regeneron 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About REGN
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara.
REGN Key Statistics
REGN News
If you have ever wondered whether now is the right time to buy, hold, or reconsider Regeneron Pharmaceuticals, you are definitely not alone. The company has bee...
Regeneron Pharmaceuticals, Inc. REGN on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo...
In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Regeneron, with a price target of $640.00. Elevate Your Investing Str...
Analyst ratings
79%
of 28 ratingsMore REGN News
Regeneron (REGN) Pharmaceuticals announced five-year follow-up results on overall survival from the Phase 3 EMPOWER-Lung 3 trial, which evaluated Libtayo plus p...
Sandoz (SDZNY) announced that it has reached an agreement with Regeneron Pharmaceuticals (REGN), to resolve all patent disputes between the two companies relati...